Edition:
United States

Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21


Tuesday, 8 May 2018 04:00pm EDT 

May 8 (Reuters) - Sunesis Pharmaceuticals Inc ::SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.Q1 REVENUE $200,000 VERSUS I/B/E/S VIEW $200,000.QTRLY LOSS PER SHARE $0.21.